|
Volumn 7, Issue 1, 2001, Pages 58-
|
Antiremodeling effects on the left ventricle during beta-blockage with metaprolol in the treatment of chronic heart failure
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
METOPROLOL;
PLACEBO;
ARTICLE;
BETA ADRENERGIC RECEPTOR BLOCKING;
CHRONIC DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME;
HEART LEFT VENTRICLE FUNCTION;
HEART LEFT VENTRICLE VOLUME;
HEART VENTRICLE REMODELING;
HUMAN;
MORTALITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
|
EID: 0035121641
PISSN: 10797998
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|